2234 GMT - The latest commentary by competitors of Nufarm supports Bell Potter's buy call on the crop-chemicals supplier. "Recent peer reporting has highlighted continued margin recovery, with trade flows indicating a solid level of inventory rebuild ahead of major selling windows," analyst Jonathan Snape says. Bell Potter expects Nufarm's 1H to show a continuation of the margin recovery story that became evident in 2H of FY 2025 in its crop protection business. It also expects a material turnaround in Omega-3 earnings. "The foundations for 2H selling windows look positive with the potential for prolonged Middle East conflict to elevate crop protection pricing," the bank adds. It retains a A$3.60/share price target on Nufarm, which ended Thursday at A$2.09. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
March 05, 2026 17:34 ET (22:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.